Items 11 to 16 of 16 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Ecotin, E. coli | 87928-05-0 | sc-221575 | 100 µg | $259.00 | ||
Ecotin, derived from E. coli, functions as a Factor X by exhibiting a high affinity for serine proteases, effectively blocking their activity. Its unique molecular architecture enables it to form stable complexes with target enzymes, disrupting their catalytic function. The compound showcases remarkable specificity and rapid binding kinetics, allowing for swift modulation of proteolytic pathways. This selective inhibition alters the dynamics of protein interactions, influencing various biological processes. | ||||||
BMS-740808 | 280118-23-2 | sc-364445 sc-364445A | 10 mg 50 mg | $480.00 $1455.00 | ||
BMS-740808 acts as a Factor X through its distinctive ability to selectively engage with specific protease active sites, leading to the formation of transient enzyme-inhibitor complexes. Its unique structural features facilitate precise molecular recognition, enhancing its interaction with target proteins. The compound demonstrates notable reaction kinetics, characterized by a rapid association and dissociation rate, which fine-tunes the modulation of enzymatic activity and influences downstream signaling pathways. | ||||||
Fondaparinux | 104993-28-4 | sc-507424 | 10 mg | $297.00 | ||
An indirect factor Xa inhibitor that indirectly inhibits factor Xa through its interaction with antithrombin III. It is used for prophylaxis of VTE. | ||||||
Rivaroxaban-d4 | 1132681-38-9 | sc-219982 | 1 mg | $388.00 | 3 | |
Rivaroxaban-d4 functions as a Factor X inhibitor by exhibiting a high affinity for the active site of the enzyme, disrupting the coagulation cascade. Its deuterated structure enhances stability and alters isotopic labeling, allowing for precise tracking in biochemical assays. The compound's unique binding dynamics promote a conformational change in the enzyme, effectively hindering its catalytic function. This specificity in molecular interaction underscores its role in modulating hemostatic processes. | ||||||
Apixaban-13C, d3 | 1261393-15-0 | sc-480057 | 2.5 mg | $340.00 | ||
Apixaban-13C, d3 acts as a selective Factor X inhibitor, characterized by its unique isotopic labeling that facilitates advanced analytical techniques. Its distinct molecular interactions involve a strong binding affinity to the enzyme's active site, leading to a significant alteration in the enzyme's conformation. This compound exhibits unique reaction kinetics, allowing for a detailed understanding of coagulation pathways and enzyme regulation, making it a valuable tool for studying hemostatic mechanisms. | ||||||
Warfarin | 81-81-2 | sc-205888 sc-205888A | 1 g 10 g | $72.00 $162.00 | 7 | |
An anticoagulant that inhibits the synthesis of vitamin K-dependent clotting factors, including factor X. It has been widely used for many years for long-term anticoagulation in various conditions. |